DK0406745T3 - Antibiotiske GE 2270 faktorer A1, A2, A3 og H - Google Patents

Antibiotiske GE 2270 faktorer A1, A2, A3 og H

Info

Publication number
DK0406745T3
DK0406745T3 DK90112547.6T DK90112547T DK0406745T3 DK 0406745 T3 DK0406745 T3 DK 0406745T3 DK 90112547 T DK90112547 T DK 90112547T DK 0406745 T3 DK0406745 T3 DK 0406745T3
Authority
DK
Denmark
Prior art keywords
antibiotic
factors
medicaments
directed
treatment
Prior art date
Application number
DK90112547.6T
Other languages
Danish (da)
English (en)
Inventor
Enrico Selva
Paolo Tavecchia
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of DK0406745T3 publication Critical patent/DK0406745T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
DK90112547.6T 1989-07-04 1990-07-02 Antibiotiske GE 2270 faktorer A1, A2, A3 og H DK0406745T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89112171 1989-07-04

Publications (1)

Publication Number Publication Date
DK0406745T3 true DK0406745T3 (da) 1995-02-27

Family

ID=8201585

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90112547.6T DK0406745T3 (da) 1989-07-04 1990-07-02 Antibiotiske GE 2270 faktorer A1, A2, A3 og H

Country Status (11)

Country Link
US (2) US5139778A (de)
EP (1) EP0406745B1 (de)
JP (1) JP2997510B2 (de)
KR (1) KR0165673B1 (de)
AT (1) ATE117724T1 (de)
CA (1) CA2020346C (de)
DE (1) DE69016284T2 (de)
DK (1) DK0406745T3 (de)
ES (1) ES2066914T3 (de)
GR (1) GR3015052T3 (de)
IE (1) IE67437B1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406745B1 (de) * 1989-07-04 1995-01-25 GRUPPO LEPETIT S.p.A. Antibiotikum GE 22270, Faktoren A1,A2,A3 und H
DK0451486T3 (da) * 1990-03-08 1995-05-08 Lepetit Spa Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
EP0529410B1 (de) * 1991-08-30 1998-02-25 Biosearch Italia S.p.A. Faktor C2a des Antibiotikums CE 2270
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
SI0801655T1 (en) * 1995-02-07 1998-08-31 Biosearch Italia S.P.A. Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics
JP3518606B2 (ja) 1995-02-07 2004-04-12 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ Ｇｅ２２７０及びｇｅ２２７０−様抗生物質の塩基性オキサゾリン−アミド誘導体
JP2000505438A (ja) * 1996-02-14 2000-05-09 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ＧＥ２２７０因子Ｃ▲下２ａ▼、Ｄ▲下２▼およびＥの誘導体
WO2003105881A1 (en) * 2002-06-17 2003-12-24 Vicuron Pharmaceuticals Inc. Use of amide derivative of ge 2270 factor a3 for the treatment of acne
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
EA200900816A1 (ru) * 2006-12-20 2009-12-30 Новартис Аг Антибактериальные соединения и способы их получения
PE20091108A1 (es) 2007-12-12 2009-08-24 Novartis Ag Aminotiazoles y sus usos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR77567B (de) * 1982-08-26 1984-09-24 Lepetit Spa
GB8323382D0 (en) * 1983-08-31 1983-10-05 Lepetit Spa Antibiotic sb 22484
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
EP0406745B1 (de) * 1989-07-04 1995-01-25 GRUPPO LEPETIT S.p.A. Antibiotikum GE 22270, Faktoren A1,A2,A3 und H

Also Published As

Publication number Publication date
CA2020346C (en) 2000-10-10
IE902405A1 (en) 1991-06-19
EP0406745B1 (de) 1995-01-25
US5139778A (en) 1992-08-18
US5547666A (en) 1996-08-20
ES2066914T3 (es) 1995-03-16
KR910003107A (ko) 1991-02-26
JPH0363289A (ja) 1991-03-19
ATE117724T1 (de) 1995-02-15
JP2997510B2 (ja) 2000-01-11
IE67437B1 (en) 1996-04-03
KR0165673B1 (ko) 1999-01-15
GR3015052T3 (en) 1995-05-31
DE69016284T2 (de) 1995-05-24
DE69016284D1 (de) 1995-03-09
EP0406745A1 (de) 1991-01-09
CA2020346A1 (en) 1991-01-05

Similar Documents

Publication Publication Date Title
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
ATE147757T1 (de) Propanolamin-cyclohexapeptide
ATE144780T1 (de) Megakaryocytopoietischer faktor
DK0675900T3 (da) Antibiotika GE 37468 A, B og C
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
EP0359062A3 (de) Antibiotikum GE 2270
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms